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Lymphangiomas are congenital anomalies of 
the lymphatic system. These are benign fluid-
filled tumours of the lymphatic vessels that 
may infiltrate or cause displacement of 
adjacent structures. Lymphangiomas are 
known to affect about 1 in 6000 live births, 
with approximately 50% presenting at birth 
and 90% becoming apparent at two years of 
age.1 Retroperitoneal lymphangiomas are rare, 
accounting for only 1% of cases.2 Foetal 
lymphangiomas may be associated with other 
problems and their prognosis depends on the 
location, size and the presence of other 
associated abnormalities. Here, we report a 
case of foetal retroperitoneal lymphangioma 
diagnosed in the third trimester of pregnancy. 
CASE REPORT 
A 35-year-old Maltese lady, who was in her first 
pregnancy, was noted that her foetus had a 
large multiseptated right sided abdominal 
mass on routine visit at 33 weeks of gestation. 
(Figure 1). No other anomalies were detected. 
Previous ultrasound scans including a detailed 
anomaly scan at 21 weeks and a 4D scan at 28 
weeks of gestation were normal. For further 
characterisation of the mass, a magnetic 
resonance (MR) imaging of the pelvis was 
carried out two weeks later and the diagnosis 
of a retroperitoneal lymphangioma was 
confirmed (Figure 2). 
Figure 1 Multiseptated hypoechogenic avascular abdominal mass measuring 5.36cm by 4.55cm 
at the level of the lumbar spine on ultrasonography. 
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Figure 2 MR sagittal image of the mother showing a large cystic abnormality that is occupying 
the right half of the foetal abdomen (white arrow).  
The case was discussed at the multidisciplinary 
team meeting and together with the parents a 
plan for an elective caesarean section at 39 
weeks of gestation was made. The mother 
presented at 37+2 weeks with spontaneous 
rupture of membranes and the baby was 
delivered via an emergency lower segment 
caesarean section and was transferred to 
neonatal paediatric intensive unit for close 
monitoring.  
On examination, the baby was found to be 
pink, haemodynamically stable with no 
obvious dysmorphic features and soft 
abdomen. Chest and abdominal X-rays were 
normal. An ultrasound of the abdomen was 
performed on day two of life and a multicystic 
abnormality was noted to be occupying the 
right half of the abdomen, extending from the 
liver edge down to the pelvis measuring 
approximately 7cm by 4cm by 5cm. This further 
confirmed the antenatal diagnosis of 
retroperitoneal lymphangioma.  
The baby remained well and was deemed fit 
for discharge on day four with a plan to repeat 
ultrasound abdomen after six weeks and a 
repeat MR abdomen and pelvis in 3 months 
time. 
DISCUSSION 
Lymphangioma is a benign hamartoma of the 
lymphatic system, consisting of multiple 
dilated vessels. These arise due to a defect in 
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the development of the lymphatic system, 
which usually develop from the sixth week of 
gestation.3 Lymphangiomas can be classified 
histologically into 3 main types; simple 
lymphangiomas consisting of lymphatic 
capillaries, cavernous lymphangiomas which 
are made up of larger lymphatic vessels with 
fibrous adventitia, and cystic lymphangiomas 
which consist of multiple cysts. All the three 
types may coexist within the same lesion.3 
Approximately 75% of lymphangiomas are 
located in the head and neck, while the other 
25% involve extremities (11%), trunk (11%), 
abdomen and genitalia (3%), or mediastinum 
(1%).4 Abdominal lymphangiomas are reported 
to occur most commonly in the mesentery of 
the small bowel, with the retroperitoneum 
being the second most common site.4  
Foetal lymphangiomas are frequently 
associated with karyotypic or other 
abnormalities like polyhydramnios, skin 
oedema and hydrops, thus making prenatal 
diagnosis important.5 Although spontaneous 
regression can sometimes occur in a foetal 
lymphangioma with normal chromosomes, 
large lymphangiomas require a perinatal 
multidisciplinary team approach. Here the 
possible management options such as prenatal 
aspiration of the cyst, elective caesarean 
section, or a delivery mode which will avoid 
foetal damage are dicussed.6 Accurate 
prenatal diagnosis permits a planned delivery, 
adequate intrapartum monitoring and 
immediate postnatal resuscitation which could 
lead to an improved prognosis.  
On ultrasonography and MR imaging, cystic 
lymphangiomas appear as sharply defined, 
unilocular or multilocular cystic lesions, with 
thick or thin walled septa. On ultrasound, the 
fluid may be anechoic, and there may be 
variable internal echoes or even fluid filled 
levels, due to bleeding and fibrin deposition.7 
In our case, both antenatal sonography and MR 
imaging accurately diagnosed the 
retroperitoneal lymphangioma. The accuracy, 
safety, immediate availability and its low cost 
had made ultrasonography the imaging 
modality of choice in the antenatal assessment 
for foetal anomalies.8 However, with the 
advances in MR imaging, this modality has 
become a useful tool for the prenatal 
diagnosis of complex foetal anomalies. In 
addition, MR imaging has the additional 
benefit of providing more comprehensive 
images, accurately delineates the exact extent 
of the lesion and it is not operator-dependent.5 
MR imaging can also provide improved 
prenatal parental counselling and postnatal 
therapeutic planning.9 
The treatment of choice of retroperitoneal 
lymphangiomas is complete surgical excision. 
The long-term prognosis is excellent if 
complete excision has been achieved. If not, 
the child needs to be followed up with serial 
scans to exclude recurrence of the lesion. 
Another alternative treatment is image-
guided percutaneous catheter drainage of 
lymphangioma followed by sclerotherapy.10 
Successful outcomes have been reported 
following the use of intralesional bleomycin, 
sclerotherapy with OK-432, or percutaneous 
embolization with Ethibloc.2,11,12  
In conclusion, foetal retroperitoneal 
lymphangiomas are very rare benign tumours 
which can be accurately diagnosed prenatally 
using a combination of ultrasonography and 
MR imaging.  A multidisciplinary perinatal team 
approach should be used to manage such cases 
and the prenatal diagnosis is crucial in the 
management and prognosis of infants with 
lymphangiomas.  
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